Gaviscon and Heart disease - a phase IV clinical study of FDA data

Summary:

Heart disease is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Nexium, and have Hiatal hernia.

The phase IV clinical study analyzes which people have Heart disease when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Heart disease?

Heart disease is found to be associated with 1,055 drugs and 1,444 conditions by eHealthMe. Check the latest studies of Heart disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 11 people (0.09%) have Heart disease.

Among these 11 people:

How long have people been on Gaviscon when they have Heart disease? *

What is the gender of people who have Heart disease when taking Gaviscon? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Heart disease when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

What are other side effects people have besides Heart disease? *

Osteoporosis (bones weak and more likely to break): 7 people, 63.64%
Depression: 6 people, 54.55%
Bone Disorder: 5 people, 45.45%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 45.45%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 36.36%
Cataract (clouding of the lens inside the eye): 4 people, 36.36%
Femur Fracture: 4 people, 36.36%
Hip Fracture: 3 people, 27.27%
Lower Limb Fracture: 3 people, 27.27%
Intervertebral Disc Degeneration (spinal disc degeneration): 3 people, 27.27%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 27.27%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 27.27%
Pain: 2 people, 18.18%
Blood Pressure Abnormal: 2 people, 18.18%
High Blood Cholesterol: 2 people, 18.18%
Thyroid Diseases: 1 person, 9.09%
Gastric Disorder (disease of stomach): 1 person, 9.09%
Blood Disorder: 1 person, 9.09%
Constipation: 1 person, 9.09%
Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Heart disease?

- Check whether Heart disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Heart disease treatments and more:

Heart disease (42,698 reports)

How severe was Heart disease and when was it recovered:

Heart disease in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Heart disease and drugs with ingredients of aluminum hydroxide; magnesium trisilicate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart disease:

Heart disease (1,055 drugs)

Browse all the conditions that are associated with Heart disease:

Heart disease (1,444 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.